Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × CA-125 Antigen × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 3 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Sarcoma 1 Neoplasm Invasiveness 1 Myofibroma 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Ovarian Epithelial 1

Interventions

Blood Specimen Collection 8 Surveys and Questionnaires 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Mammography 5 Cyclophosphamide 5 Colonoscopy 5 Biopsy 5 Prednisone 4 Positron Emission Tomography Computed Tomography 4 Magnetic Resonance Imaging 4 Lenalidomide 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Melphalan 3 Liquid Biopsy 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Urination 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Injections 2 Immunohistochemistry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02296307 2024-05-02

DOvEE

McGill University

13,600 enrolled

Disease, Neoplasm Invasiveness, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡